APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cobalamin API

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cobalamin API Industry Growth and Trends Forecast to 2032

23 December 2025103 pages

Choose your research edition.

Industry ResearchCobalamin API Industry Research Report 2026129 pages · $2,950 USDIndustry Growth & TrendsGlobal Cobalamin API Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Cobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cobalamin API Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Cobalamin API Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Cobalamin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cobalamin API include Teva (Actavis), Novartis, Merck, Mylan, Pfizer, Huaxin Pharmaceutical, Sanofi-Aventis, RLG Group and Luitpold Pharmaceuticals (Daiichi Sankyo), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cobalamin API market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cobalamin API market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cobalamin API market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cobalamin API.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cobalamin API market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cobalamin API Market by Company

Teva (Actavis)

Novartis

Merck

Mylan

Pfizer

Huaxin Pharmaceutical

Sanofi-Aventis

RLG Group

Luitpold Pharmaceuticals (Daiichi Sankyo)

Jamieson

Endo International

CCEPCD

Bayer HealthCare

ANGELINI

Cobalamin API Segment by Type

Purity≥99%

Purity<99%

Cobalamin API Segment by Application

Cobalamin Injection

Cobalamin Spray

Oral Cobalamin

Cobalamin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cobalamin API manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Purity≥99% Table 2. Major Company of Purity<99% Table 3. Global Cobalamin API Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cobalamin API Sales by Type (2021-2026) & (t) Table 5. Global Cobalamin API Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cobalamin API Sales Market Share in Value by Type (2021-2026) Table 8. Global Cobalamin API Price by Type (2021-2026) & (USD/kg) Table 9. Global Cobalamin API Sales by Type (2027-2032) & (t) Table 10. Global Cobalamin API Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cobalamin API Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cobalamin API Sales Market Share in Value by Type (2027-2032) Table 13. Global Cobalamin API Price by Type (2027-2032) & (USD/kg) Table 14. North America Cobalamin API Sales by Type (2021-2026) & (t) Table 15. North America Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cobalamin API Sales by Type (2021-2026) & (t) Table 17. Europe Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cobalamin API Sales by Type (2021-2026) & (t) Table 19. Asia-Pacific Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cobalamin API Sales by Type (2021-2026) & (t) Table 21. Latin America Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cobalamin API Sales by Type (2021-2026) & (t) Table 23. Middle East and Africa Cobalamin API Sales by Type (2021-2026) & (US$ Million) Table 24. Cobalamin API Industry Trends Table 25. Cobalamin API Industry Drivers Table 26. Cobalamin API Industry Opportunities and Challenges Table 27. Cobalamin API Industry Restraints Table 28. Global Cobalamin API Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cobalamin API Revenue Market Share by Company (2021-2026) Table 30. Global Cobalamin API Sales by Company (2021-2026) & (t) Table 31. Global Cobalamin API Sales Share by Company (2021-2026) Table 32. Global Cobalamin API Market Price by Company (2021-2026) & (USD/kg) Table 33. Global Cobalamin API Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cobalamin API Major Company Production Sites and Headquarters Table 35. Global Cobalamin API Company, Product Type & Application Table 36. Global Cobalamin API Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cobalamin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cobalamin API Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cobalamin API Sales by Region (2021-2026) & (t) Table 41. Global Cobalamin API Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cobalamin API Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cobalamin API Sales Market Share in Value by Region (2021-2026) Table 44. Global Cobalamin API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 45. Global Cobalamin API Sales by Region (2027-2032) & (t) Table 46. Global Cobalamin API Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cobalamin API Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cobalamin API Sales Market Share in Value by Region (2027-2032) Table 49. Global Cobalamin API Sales (t), Value (US$ Million), Price (USD/kg) and Gross Margin (2027-2032) Table 50. Global Cobalamin API Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cobalamin API Sales by Application (2021-2026) & (t) Table 52. Global Cobalamin API Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cobalamin API Sales Market Share in Value by Application (2021-2026) Table 55. Global Cobalamin API Price by Application (2021-2026) & (USD/kg) Table 56. Global Cobalamin API Sales by Application (2027-2032) & (t) Table 57. Global Cobalamin API Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cobalamin API Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cobalamin API Sales Market Share in Value by Application (2027-2032) Table 60. Global Cobalamin API Price by Application (2027-2032) & (USD/kg) Table 61. North America Cobalamin API Sales by Application (2021-2026) & (t) Table 62. North America Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cobalamin API Sales by Application (2021-2026) & (t) Table 64. Europe Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cobalamin API Sales by Application (2021-2026) & (t) Table 66. Asia-Pacific Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cobalamin API Sales by Application (2021-2026) & (t) Table 68. Latin America Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cobalamin API Sales by Application (2021-2026) & (t) Table 70. Middle East and Africa Cobalamin API Sales by Application (2021-2026) & (US$ Million) Table 71. Teva (Actavis) Company Information Table 72. Teva (Actavis) Business Overview Table 73. Teva (Actavis) Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 74. Teva (Actavis) Cobalamin API Product Portfolio Table 75. Teva (Actavis) Recent Development Table 76. Novartis Company Information Table 77. Novartis Business Overview Table 78. Novartis Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 79. Novartis Cobalamin API Product Portfolio Table 80. Novartis Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 84. Merck Cobalamin API Product Portfolio Table 85. Merck Recent Development Table 86. Mylan Company Information Table 87. Mylan Business Overview Table 88. Mylan Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 89. Mylan Cobalamin API Product Portfolio Table 90. Mylan Recent Development Table 91. Pfizer Company Information Table 92. Pfizer Business Overview Table 93. Pfizer Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 94. Pfizer Cobalamin API Product Portfolio Table 95. Pfizer Recent Development Table 96. Huaxin Pharmaceutical Company Information Table 97. Huaxin Pharmaceutical Business Overview Table 98. Huaxin Pharmaceutical Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 99. Huaxin Pharmaceutical Cobalamin API Product Portfolio Table 100. Huaxin Pharmaceutical Recent Development Table 101. Sanofi-Aventis Company Information Table 102. Sanofi-Aventis Business Overview Table 103. Sanofi-Aventis Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 104. Sanofi-Aventis Cobalamin API Product Portfolio Table 105. Sanofi-Aventis Recent Development Table 106. RLG Group Company Information Table 107. RLG Group Business Overview Table 108. RLG Group Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 109. RLG Group Cobalamin API Product Portfolio Table 110. RLG Group Recent Development Table 111. Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information Table 112. Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview Table 113. Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 114. Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Product Portfolio Table 115. Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Development Table 116. Jamieson Company Information Table 117. Jamieson Business Overview Table 118. Jamieson Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 119. Jamieson Cobalamin API Product Portfolio Table 120. Jamieson Recent Development Table 121. Endo International Company Information Table 122. Endo International Business Overview Table 123. Endo International Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 124. Endo International Cobalamin API Product Portfolio Table 125. Endo International Recent Development Table 126. CCEPCD Company Information Table 127. CCEPCD Business Overview Table 128. CCEPCD Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 129. CCEPCD Cobalamin API Product Portfolio Table 130. CCEPCD Recent Development Table 131. Bayer HealthCare Company Information Table 132. Bayer HealthCare Business Overview Table 133. Bayer HealthCare Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 134. Bayer HealthCare Cobalamin API Product Portfolio Table 135. Bayer HealthCare Recent Development Table 136. ANGELINI Company Information Table 137. ANGELINI Business Overview Table 138. ANGELINI Cobalamin API Sales (t), Revenue (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 139. ANGELINI Cobalamin API Product Portfolio Table 140. ANGELINI Recent Development Table 141. North America Cobalamin API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 142. North America Cobalamin API Sales by Country (2021-2026) & (t) Table 143. North America Cobalamin API Sales Market Share by Country (2021-2026) Table 144. North America Cobalamin API Sales Forecast by Country (2027-2032) & (t) Table 145. North America Cobalamin API Sales Market Share Forecast by Country (2027-2032) Table 146. North America Cobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Cobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Cobalamin API Market Share by Country (2021-2026) Table 149. North America Cobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Cobalamin API Market Share Forecast by Country (2027-2032) Table 151. Europe Cobalamin API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 152. Europe Cobalamin API Sales by Country (2021-2026) & (t) Table 153. Europe Cobalamin API Sales Market Share by Country (2021-2026) Table 154. Europe Cobalamin API Sales Forecast by Country (2027-2032) & (t) Table 155. Europe Cobalamin API Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Cobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Cobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Cobalamin API Market Share by Country (2021-2026) Table 159. Europe Cobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Cobalamin API Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Cobalamin API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Cobalamin API Sales by Country (2021-2026) & (t) Table 163. Asia-Pacific Cobalamin API Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Cobalamin API Sales Forecast by Country (2027-2032) & (t) Table 165. Asia-Pacific Cobalamin API Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Cobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Cobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Cobalamin API Market Share by Country (2021-2026) Table 169. Asia-Pacific Cobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Cobalamin API Market Share Forecast by Country (2027-2032) Table 171. Latin America Cobalamin API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 172. Latin America Cobalamin API Sales by Country (2021-2026) & (t) Table 173. Latin America Cobalamin API Sales Market Share by Country (2021-2026) Table 174. Latin America Cobalamin API Sales Forecast by Country (2027-2032) & (t) Table 175. Latin America Cobalamin API Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Cobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Cobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Cobalamin API Market Share by Country (2021-2026) Table 179. Latin America Cobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Cobalamin API Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Cobalamin API Market Size Growth Rate (CAGR) by Country (t): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Cobalamin API Sales by Country (2021-2026) & (t) Table 183. Middle East and Africa Cobalamin API Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Cobalamin API Sales Forecast by Country (2027-2032) & (t) Table 185. Middle East and Africa Cobalamin API Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Cobalamin API Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Cobalamin API Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Cobalamin API Market Share by Country (2021-2026) Table 189. Middle East and Africa Cobalamin API Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Cobalamin API Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Cobalamin API Distributors List Table 194. Cobalamin API Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Cobalamin API Image Figure 2. Global Cobalamin API Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cobalamin API Market Size (2021-2032) & (US$ Million) Figure 4. Global Cobalamin API Sales (2021-2032) & (t) Figure 5. Purity≥99% Image Figure 6. Global Purity≥99% Sales YoY Growth (2021-2032) & (t) Figure 7. Purity<99% Image Figure 8. Global Purity<99% Sales YoY Growth (2021-2032) & (t) Figure 9. Global Cobalamin API Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cobalamin API Market Share by Type 2025 VS 2032 Figure 11. North America Cobalamin API Sales Market Share in Volume by Type in 2025 Figure 12. North America Cobalamin API Sales Market Share in Value by Type in 2025 Figure 13. Europe Cobalamin API Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cobalamin API Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cobalamin API Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cobalamin API Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cobalamin API Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cobalamin API Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cobalamin API Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cobalamin API Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cobalamin API Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Cobalamin Injection Image Figure 24. Global Cobalamin Injection Sales YoY Growth (2021-2032) & (t) Figure 25. Cobalamin Spray Image Figure 26. Global Cobalamin Spray Sales YoY Growth (2021-2032) & (t) Figure 27. Oral Cobalamin Image Figure 28. Global Oral Cobalamin Sales YoY Growth (2021-2032) & (t) Figure 29. Global Cobalamin API Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Cobalamin API Market Share by Application 2025 VS 2032 Figure 31. North America Cobalamin API Sales Market Share in Volume by Application in 2025 Figure 32. North America Cobalamin API Sales Market Share in Value by Application in 2025 Figure 33. Europe Cobalamin API Sales Market Share in Volume by Application in 2025 Figure 34. Europe Cobalamin API Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Cobalamin API Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Cobalamin API Sales Market Share in Value by Application in 2025 Figure 37. Latin America Cobalamin API Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Cobalamin API Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Cobalamin API Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Cobalamin API Sales Market Share in Value by Application in 2025 Figure 41. North America Cobalamin API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 42. North America Cobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Cobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Cobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cobalamin API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 46. Europe Cobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Cobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cobalamin API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 50. Asia-Pacific Cobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Cobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cobalamin API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 54. Latin America Cobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Cobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cobalamin API Sales by Country: 2021 VS 2025 VS 2032 (t) Figure 58. Middle East and Africa Cobalamin API Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cobalamin API Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Cobalamin API Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Cobalamin API Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Cobalamin API Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥99%
  • Purity<99%
Applications
  • Cobalamin Injection
  • Cobalamin Spray
  • Oral Cobalamin
Companies covered
  • Teva (Actavis)
  • Novartis
  • Merck
  • Mylan
  • Pfizer
  • Huaxin Pharmaceutical
  • Sanofi-Aventis
  • RLG Group
  • Luitpold Pharmaceuticals (Daiichi Sankyo)
  • Jamieson
  • Endo International
  • CCEPCD
  • Bayer HealthCare
  • ANGELINI

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cobalamin API Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cobalamin API Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cobalamin API Market by Type
  6. 1.3.1 Purity≥99%
  7. 1.3.2 Purity<99%
  8. 1.4 Global Cobalamin API Market Size by Type
  9. 1.4.1 Global Cobalamin API Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cobalamin API Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cobalamin API Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cobalamin API Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cobalamin API Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cobalamin API Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cobalamin API Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cobalamin API Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cobalamin API Industry Trends
  2. 2.2 Cobalamin API Industry Drivers
  3. 2.3 Cobalamin API Industry Opportunities and Challenges
  4. 2.4 Cobalamin API Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cobalamin API Revenue (2021-2026)
  2. 3.2 Global Top Players by Cobalamin API Sales (2021-2026)
  3. 3.3 Global Top Players by Cobalamin API Price (2021-2026)
  4. 3.4 Global Cobalamin API Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cobalamin API Major Company Production Sites & Headquarters
  6. 3.6 Global Cobalamin API Company, Product Type & Application
  7. 3.7 Global Cobalamin API Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cobalamin API Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cobalamin API Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cobalamin API Tier 1, Tier 2, and Tier 3
4 Cobalamin API Regional Status and Outlook
  1. 4.1 Global Cobalamin API Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cobalamin API Historic Market Size by Region
  3. 4.2.1 Global Cobalamin API Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cobalamin API Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cobalamin API Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cobalamin API Forecasted Market Size by Region
  7. 4.3.1 Global Cobalamin API Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cobalamin API Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cobalamin API Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cobalamin API by Application
  1. 5.1 Cobalamin API Market by Application
  2. 5.1.1 Cobalamin Injection
  3. 5.1.2 Cobalamin Spray
  4. 5.1.3 Oral Cobalamin
  5. 5.2 Global Cobalamin API Market Size by Application
  6. 5.2.1 Global Cobalamin API Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cobalamin API Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cobalamin API Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cobalamin API Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cobalamin API Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cobalamin API Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cobalamin API Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cobalamin API Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva (Actavis)
  2. 6.1.1 Teva (Actavis) Company Information
  3. 6.1.2 Teva (Actavis) Business Overview
  4. 6.1.3 Teva (Actavis) Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva (Actavis) Cobalamin API Product Portfolio
  6. 6.1.5 Teva (Actavis) Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Novartis Cobalamin API Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Cobalamin API Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Mylan
  20. 6.4.1 Mylan Company Information
  21. 6.4.2 Mylan Business Overview
  22. 6.4.3 Mylan Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Mylan Cobalamin API Product Portfolio
  24. 6.4.5 Mylan Recent Developments
  25. 6.5 Pfizer
  26. 6.5.1 Pfizer Company Information
  27. 6.5.2 Pfizer Business Overview
  28. 6.5.3 Pfizer Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pfizer Cobalamin API Product Portfolio
  30. 6.5.5 Pfizer Recent Developments
  31. 6.6 Huaxin Pharmaceutical
  32. 6.6.1 Huaxin Pharmaceutical Company Information
  33. 6.6.2 Huaxin Pharmaceutical Business Overview
  34. 6.6.3 Huaxin Pharmaceutical Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huaxin Pharmaceutical Cobalamin API Product Portfolio
  36. 6.6.5 Huaxin Pharmaceutical Recent Developments
  37. 6.7 Sanofi-Aventis
  38. 6.7.1 Sanofi-Aventis Company Information
  39. 6.7.2 Sanofi-Aventis Business Overview
  40. 6.7.3 Sanofi-Aventis Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Sanofi-Aventis Cobalamin API Product Portfolio
  42. 6.7.5 Sanofi-Aventis Recent Developments
  43. 6.8 RLG Group
  44. 6.8.1 RLG Group Company Information
  45. 6.8.2 RLG Group Business Overview
  46. 6.8.3 RLG Group Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 RLG Group Cobalamin API Product Portfolio
  48. 6.8.5 RLG Group Recent Developments
  49. 6.9 Luitpold Pharmaceuticals (Daiichi Sankyo)
  50. 6.9.1 Luitpold Pharmaceuticals (Daiichi Sankyo) Company Information
  51. 6.9.2 Luitpold Pharmaceuticals (Daiichi Sankyo) Business Overview
  52. 6.9.3 Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Luitpold Pharmaceuticals (Daiichi Sankyo) Cobalamin API Product Portfolio
  54. 6.9.5 Luitpold Pharmaceuticals (Daiichi Sankyo) Recent Developments
  55. 6.10 Jamieson
  56. 6.10.1 Jamieson Company Information
  57. 6.10.2 Jamieson Business Overview
  58. 6.10.3 Jamieson Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Jamieson Cobalamin API Product Portfolio
  60. 6.10.5 Jamieson Recent Developments
  61. 6.11 Endo International
  62. 6.11.1 Endo International Company Information
  63. 6.11.2 Endo International Business Overview
  64. 6.11.3 Endo International Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Endo International Cobalamin API Product Portfolio
  66. 6.11.5 Endo International Recent Developments
  67. 6.12 CCEPCD
  68. 6.12.1 CCEPCD Company Information
  69. 6.12.2 CCEPCD Business Overview
  70. 6.12.3 CCEPCD Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 CCEPCD Cobalamin API Product Portfolio
  72. 6.12.5 CCEPCD Recent Developments
  73. 6.13 Bayer HealthCare
  74. 6.13.1 Bayer HealthCare Company Information
  75. 6.13.2 Bayer HealthCare Business Overview
  76. 6.13.3 Bayer HealthCare Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Bayer HealthCare Cobalamin API Product Portfolio
  78. 6.13.5 Bayer HealthCare Recent Developments
  79. 6.14 ANGELINI
  80. 6.14.1 ANGELINI Company Information
  81. 6.14.2 ANGELINI Business Overview
  82. 6.14.3 ANGELINI Cobalamin API Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 ANGELINI Cobalamin API Product Portfolio
  84. 6.14.5 ANGELINI Recent Developments
7 North America by Country
  1. 7.1 North America Cobalamin API Sales by Country
  2. 7.1.1 North America Cobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cobalamin API Sales by Country (2021-2026)
  4. 7.1.3 North America Cobalamin API Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cobalamin API Market Size by Country
  6. 7.2.1 North America Cobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cobalamin API Market Size by Country (2021-2026)
  8. 7.2.3 North America Cobalamin API Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cobalamin API Sales by Country
  2. 8.1.1 Europe Cobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cobalamin API Sales by Country (2021-2026)
  4. 8.1.3 Europe Cobalamin API Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cobalamin API Market Size by Country
  6. 8.2.1 Europe Cobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cobalamin API Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cobalamin API Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cobalamin API Sales by Country
  2. 9.1.1 Asia-Pacific Cobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cobalamin API Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cobalamin API Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cobalamin API Market Size by Country
  6. 9.2.1 Asia-Pacific Cobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cobalamin API Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cobalamin API Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cobalamin API Sales by Country
  2. 10.1.1 South America Cobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cobalamin API Sales by Country (2021-2026)
  4. 10.1.3 South America Cobalamin API Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cobalamin API Market Size by Country
  6. 10.2.1 South America Cobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cobalamin API Market Size by Country (2021-2026)
  8. 10.2.3 South America Cobalamin API Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cobalamin API Sales by Country
  2. 11.1.1 Middle East and Africa Cobalamin API Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cobalamin API Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cobalamin API Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cobalamin API Market Size by Country
  6. 11.2.1 Middle East and Africa Cobalamin API Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cobalamin API Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cobalamin API Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cobalamin API Value Chain Analysis
  2. 12.1.1 Cobalamin API Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cobalamin API Production Mode & Process
  7. 12.2 Cobalamin API Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cobalamin API Distributors
  10. 12.2.3 Cobalamin API Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst